Multiple Doses and Regimens of Cabozantinib in Subjects With Grade IV Astrocytic Tumors in First or Second Relapse
Exelixis
Exelixis
National Institutes of Health Clinical Center (CC)
Day One Biopharmaceuticals, Inc.
Alaunos Therapeutics
University of Oklahoma
Washington University School of Medicine
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
University of California, San Francisco
University of Nebraska
City of Hope Medical Center
Rush University Medical Center
Karyopharm Therapeutics Inc
University of California, San Francisco
Indiana University
Weill Medical College of Cornell University
M.D. Anderson Cancer Center
Pediatric Brain Tumor Consortium
Massachusetts General Hospital
Northwestern University
Pfizer
Medical College of Wisconsin
Case Comprehensive Cancer Center
Medical University of South Carolina
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Pediatric Brain Tumor Consortium
Burzynski Research Institute
Burzynski Research Institute
Burzynski Research Institute
Beth Israel Medical Center
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI)
University of California, San Francisco
University of South Florida
Isarna Therapeutics GmbH
National Cancer Institute (NCI)
Case Comprehensive Cancer Center